Vgi Partners LTD Abbott Laboratories Transaction History

Vgi Partners LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $957,410 - $1.07 Million	9,500 Added 40.09%	33,197 $3.62 Million
Q4 2022 Aug 15, 2023	SELL	$95.06 - $111.52 $133,369 - $156,462	-1,403 Reduced 5.59%	23,697 $2.6 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $133,369 - $156,462	-1,403 Reduced 5.59%	23,697 $2.6 Million
Q3 2022 Aug 15, 2023	SELL	$96.76 - $112.03 $783,465 - $907,106	-8,097 Reduced 24.39%	25,100 $2.43 Million
Q2 2022 Sep 09, 2022	BUY	$102.07 - $123.37 $2.56 Million - $3.1 Million	25,100 New	25,100 $2.73 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Vgi Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Vgi Partners LTD with notifications on news.